Three psychedelic companies received vouchers for expedited FDA review: Usona, Compass Pathways, and Otsuka—NOT Resilient Pharmaceuticals. This voucher announcement is yet another vindication of our reporting on major problems and pseudoscience within Lykos’/Resilient's trials.
Journalist Rich Haridy discusses his concerns with boxing psychedelics into a medicalized container.
Rich Haridy and Dr. Samuel Douglas discuss the Australian bush doof scene.
Russell, Mike, and Neşe sit down with journalist Rich Haridy and Dr. Samuel Douglas to discuss bush doofs, Australian psychedelic commercialization, Entheogenesis Australis, Haridy's new book, and more.